Therefore, our findings could pave the way for research on developing drugs or supplements targeting GPR84, with potential applications in treating metabolic disorders such as obesity and type 2 diabetes. The gene discussed is GPR84; the disease is obesity due to melanocortin 4 receptor deficiency.